(Q36492421)

14 August 2017

Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers (English)

1 reference

14 August 2017

0 references

I M Rigter

1

1 reference

14 August 2017

H G Schipper

2

1 reference

14 August 2017

R P Koopmans

3

1 reference

14 August 2017

H J M van Kan

4

1 reference

14 August 2017

H W Frijlink

5

1 reference

14 August 2017

P A Kager

6

1 reference

14 August 2017

H-J Guchelaar

7

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Antimicrobial Agents and Chemotherapy

14 August 2017

1 reference

14 August 2017

48

1 reference

14 August 2017

3

1 reference

14 August 2017

1051-1054

1 reference

Effect of dose increase or cimetidine co-administration on albendazole bioavailability

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

Increased systemic availability of albendazole when taken with a fatty meal

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

Multicentre clinical trials of benzimidazole-carbamates in human cystic echinococcosis (phase 2)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

Albendazole in treatment of human cystic echinococcosis: 12 years of experience

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

Albendazole-soybean oil emulsion for the treatment of human cystic echinococcosis: evaluation of bioavailability and bioequivalence

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=353162

Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique

21 September 2018

1 reference

12 December 2020

Effect of surfactants on Albendazole absorption

1 reference

12 December 2020

Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine

1 reference

12 December 2020

Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide

1 reference

12 December 2020

10.1128/AAC.48.3.1051-1054.2004

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

14982808

1 reference